Pyrazole derivatives for the inhibition of cdk' s and gsk' s

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A01N 43/56 (2006.01) A61K 31/44 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2593465

The invention provides a compound of the formula (I): or salts, tautomers, solvates and N-oxides thereof; wherein: R1 is 2,6-dichlorophenyl; R2a and R2 are both hydrogen; and R3 is a group: where R4 is C1-4 alkyl. The compounds have activity as inhibitors of CDK kinases and inhibit the proliferation of cancer cells.

La présente invention concerne un composé de formule (1), ou des sels, tautomères, solvates et N-oxydes de ceux-ci; R1 désignant 2,6-dichlorophényl; R2a et R2 représentant tous les deux hydrogène; et R3 étant un groupe où R4 est alkyle en C1-4. Les composés sont actifs en tant qu'inhibiteurs des kinases dépendantes des cyclines (CDK) et inhibent la prolifération des cellules cancéreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazole derivatives for the inhibition of cdk' s and gsk' s does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazole derivatives for the inhibition of cdk' s and gsk' s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives for the inhibition of cdk' s and gsk' s will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1732397

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.